Cytek Biosciences, Inc. ('Cytek Biosciences” or 'Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the first quarter ended March 31, 2026.
Grew Strategic Reserve to Over 7,000 Bitcoin, a ~30% Increase in a Single Quarter, While Maintaining ~52% Mining Gross Margin Despite Bitcoin 's ~22% Decline MIAMI, May 6, 2026 /PRNewswire/ ...
The ADX and International Securities signed an agreement at the Made in the Emirates forum to kick off uniquely designed ...
Arm Holdings plc (NASDAQ: ARM), the company that is building the future of computing, has today published a letter to its ...
Blaize Holdings, Inc. (Nasdaq: BZAI, Nasdaq: BZAIW) (Blaize, the Company, we, our, or us), a leader in programmable, ...
Created by Gold Coast entrepreneur Jane Helman, who knows the ‘chilly girl’ struggle well, the office worker said even when ...
Alkermes plc (Nasdaq: ALKS) today reported financial results for the quarter ended March 31, 2026 and financial expectations ...
Ahead of the election, the Southern California News Group compiled a list of questions to pose to the candidates vying to ...
Ryan Cohen gained prominence by cofounding Chewy and becoming a face of the meme stock craze. Now, he's leading GameStop's ...
Russian Oil Asset Fund, known as ROAF, has launched its public website at ROAFGov.com, introducing the market to $ROAF, an energy-themed digital asset project built on Solana. The launch gives ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results